Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis
Open Access
- 18 February 2024
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 38, 101278
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Cystic Fibrosis Foundation
- Cystic Fibrosis Research Foundation (CC002-AD)
- National Institutes of Health (3UL1TR002378-05S2, P30DK125013)
This publication has 42 references indexed in Scilit:
- The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individualsScientific Reports, 2020
- Vitamin D deficiency and its treatment in cystic fibrosisJournal of Cystic Fibrosis, 2019
- Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administrationMetabolism, 2017
- Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trialsWorld Journal of Pediatrics, 2017
- Role of vitamin D on gut microbiota in cystic fibrosisThe Journal of Steroid Biochemistry and Molecular Biology, 2016
- Treatment of vitamin D deficiency in cystic fibrosisThe Journal of Steroid Biochemistry and Molecular Biology, 2016
- Role of CFTR in epithelial physiologyCellular and Molecular Life Sciences, 2016
- Inulin: Properties, health benefits and food applicationsCarbohydrate Polymers, 2016
- Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic FibrosisThe Journal of Pediatrics, 2015
- Cystic fibrosis mouse model-dependent intestinal structure and gut microbiomeMammalian Genome, 2015